IBM
IBM
$243.29
+3.96%
International Business Machines Corporation (IBM) is a global technology company that provides a diverse portfolio of software, IT consulting services, and hardware, primarily serving enterprise clients across 175 countries. As a veteran industry player with over a century of history, IBM distinguishes itself through its hybrid cloud and AI offerings, including Red Hat and watsonx, and its stronghold in mission-critical mainframe systems, serving 95% of Fortune 500 companies. Currently, the stock is under intense scrutiny following a sharp post-earnings selloff in July 2026, driven by a revenue miss and concerns that enterprise customers are reallocating IT budgets toward AI infrastructure, potentially at the expense of IBM's traditional software and consulting segments. The narrative centers on whether IBM can successfully pivot its portfolio to capitalize on AI demand, with recent acquisitions like HRL Laboratories signaling strategic investments in quantum computing, while investors debate the near-term growth trajectory and the sustainability of its dividend.…
IBM
IBM
$243.29
Related headlines
Investment Opinion: Should I buy IBM Today?
Based on the synthesis of data, I rate IBM as a Hold. The consensus analyst rating is 'buy' with an average target price of $245.35, implying a modest 4.5% upside from the current price of $234.89. However, the recent earnings miss and profit warning in July 2026 have introduced significant uncertainty, making it prudent to wait for clearer signs of stabilization before committing new capital. The thesis is that IBM's low forward P/E of 17.85x and strong free cash flow of $14.584 billion provide a valuation floor, but the company must demonstrate that it can navigate the AI-driven shift in IT spending.
Sign up to view all
IBM 12-Month Price Forecast
The AI assessment is neutral with medium confidence. IBM's valuation is not demanding, but the company faces significant execution risks in a rapidly evolving AI landscape. The key factor is whether IBM can translate its AI investments into revenue growth, as the Q2 miss suggests that customers are diverting budgets to AI-native solutions. If IBM can demonstrate sustained growth in its software segment, the stock could re-rate higher; otherwise, it may continue to underperform. I would upgrade to bullish if IBM reports two consecutive quarters of revenue growth above 5% and positive net income, and downgrade to bearish if revenue declines or the dividend is cut.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on IBM's 12-month outlook, with a consensus price target around $245.35 and implied upside of +0.8% versus the current price.
Average Target
$245.35
0 analysts
Implied Upside
+0.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$174 - $350
Analyst target range
The target price range spans from a low of $174.00 to a high of $350.00, representing a wide spread of $176, which signals high uncertainty about IBM's future performance. The low target implies a potential downside of 25.9% from the current price, likely reflecting concerns about continued revenue declines and margin compression due to AI-driven competition. The high target suggests an upside of 49.0%, assuming successful execution of its AI and hybrid cloud strategy, leading to accelerated growth and multiple expansion. The recent downgrade by HSBC and the profit warning in July 2026 have increased bearish sentiment, but the overall consensus remains positive, with many analysts viewing the selloff as an overreaction and a potential buying opportunity for long-term investors.
Bulls vs Bears: IBM Investment Factors
IBM presents a classic value-versus-growth dilemma. On the bullish side, the stock offers a low forward P/E of 17.85x, a PEG ratio of 0.35, and robust free cash flow of $14.584 billion, suggesting that the market may have overreacted to the Q2 miss. On the bearish side, the company faces significant headwinds from AI-driven budget reallocation, high debt levels, and a sharp 25% selloff that reflects deteriorating fundamentals. The most critical tension is whether IBM can successfully pivot its portfolio to capitalize on AI demand without sacrificing its traditional revenue streams. If the company can demonstrate sustained revenue growth in its software and consulting segments, the stock could re-rate higher; however, continued misses could push it toward the bear case. Currently, the bearish evidence is stronger given the recent earnings miss and negative momentum, but the valuation cushion provides some downside protection.
Bullish
- Strong Free Cash Flow Generation: IBM generated $14.584 billion in trailing twelve-month free cash flow, providing ample capacity to fund its dividend and strategic acquisitions like HRL Laboratories. This robust cash flow supports the company's ability to invest in growth areas such as hybrid cloud and AI while maintaining a stable payout.
- Attractive Forward Valuation: The forward P/E ratio of 17.85x is significantly lower than the trailing P/E of 26.07x, suggesting the market expects substantial earnings growth. With a PEG ratio of 0.35, the stock appears undervalued relative to its growth prospects, offering potential upside if the company meets consensus EPS estimates of $12.56.
- High Gross Margin Stability: IBM's gross margin stands at 58.19%, reflecting a resilient business model with strong pricing power in its software and consulting segments. Despite revenue volatility, this margin level indicates the company can maintain profitability even during periods of top-line pressure.
- Analyst Consensus Remains Positive: With a consensus rating of 'buy' and an average target price of $245.35, analysts see approximately 4.5% upside from the current price of $234.89. The high target of $350 implies a potential 49% gain, suggesting that the recent selloff may have created a buying opportunity for long-term investors.
Bearish
- Sharp Post-Earnings Selloff: IBM's stock plunged 25% in July 2026 following a Q2 revenue miss and profit warning, erasing significant market value. The stock now trades 35.3% below its 52-week high of $332.46, reflecting deep investor pessimism about near-term growth prospects.
- Revenue Growth Volatility: IBM's revenue growth has been inconsistent, with Q1 2026 showing 9.5% YoY growth but Q2 2026 experiencing a miss. The company's net loss of $1.216 billion in Q2 2026, compared to a net income of $2.194 billion in Q2 2025, highlights the fragility of its earnings power.
- High Debt Levels: IBM's debt-to-equity ratio of 2.06 indicates significant leverage, which could strain financial flexibility if interest rates remain elevated. The company's interest expense of $473 million in Q1 2026 adds pressure on profitability, especially during periods of revenue softness.
- Competitive Pressure from AI-Native Firms: The rise of AI-native competitors like Pegasystems, which missed estimates due to AI-related customer delays, signals that enterprises are shifting IT budgets toward AI infrastructure. This trend threatens IBM's traditional software and consulting segments, as seen in the Q2 2026 miss.
IBM Technical Analysis
IBM's price trend over the past year has been characterized by a significant downturn, with the stock currently trading at $234.89, down 4.97% from a year ago. This decline is more pronounced over shorter horizons: the stock has fallen 17.54% over the past three months and 19.42% year-to-date, indicating a persistent bearish momentum. The current price sits at 35.3% of its 52-week range (between the low of $199.19 and high of $332.46), placing it closer to the lower end of its annual range, which suggests the market is pricing in substantial negative sentiment and potential value opportunities, but also risks of further downside if fundamentals deteriorate.
Beta
0.71
0.71x market volatility
Max Drawdown
-37.5%
Largest decline past year
52-Week Range
$199-$332
Price range past year
Annual Return
-5.3%
Cumulative gain past year
| Period | IBM Return | S&P 500 |
|---|---|---|
| 1m | +3.1% | -1.1% |
| 3m | -10.6% | +3.0% |
| 6m | -1.2% | +15.4% |
| 1y | -5.3% | +16.2% |
| ytd | -16.5% | +12.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
IBM Fundamental Analysis
IBM's revenue trajectory has been volatile, with the most recent quarter (Q2 2026) showing a significant miss, as revenue was not reported in the provided data, but the company's gross profit of $9.907 billion and a net loss of $1.216 billion (as per cash flow data) indicate operational challenges. In Q1 2026, revenue was $15.917 billion, up 9.5% year-over-year from $14.541 billion in Q1 2025, but this growth was not sustained, as Q2 2026 saw a net loss of $1.216 billion compared to a net income of $2.194 billion in Q2 2025, reflecting a sharp deterioration. The company's revenue segments show Software as the largest contributor at $7.052 billion, followed by Consulting at $5.272 billion, but the overall growth has been inconsistent, with recent quarters showing deceleration and a notable miss in Q2 2026, which has raised concerns about the sustainability of its growth strategy.
Quarterly Revenue
$0.0B
2026-06
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
N/A
Latest Quarter
Free Cash Flow
$14.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is IBM Overvalued?
Given that IBM's trailing twelve-month net income is positive (as indicated by positive EPS of $0.038 and net margin of 15.68%), the primary valuation metric selected is the price-to-earnings (PE) ratio. The trailing PE is 26.07x, while the forward PE is 17.85x, implying that the market expects significant earnings growth in the next year, which is consistent with the consensus EPS estimate of $12.56 for the upcoming fiscal year. The gap between trailing and forward PE suggests that investors are pricing in a recovery from the recent earnings miss, but the high trailing multiple may reflect the one-time charges that depressed earnings in Q2 2026.
PE
26.1x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 11x~47x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
19.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks are elevated for IBM. The company's debt-to-equity ratio of 2.06 indicates substantial leverage, which, combined with rising interest expenses (e.g., $473 million in Q1 2026), could strain profitability if revenue growth stagnates. The Q2 2026 net loss of $1.216 billion, versus a net income of $2.194 billion in the prior year, underscores earnings volatility, partly due to one-time charges but also reflecting operational challenges. Additionally, IBM's current ratio of 0.93 suggests potential liquidity concerns, as current liabilities exceed current assets, which could limit flexibility in adverse scenarios. The reliance on a few large segments, with Software contributing $7.052 billion and Consulting $5.272 billion in Q1 2026, exposes the company to concentration risk if these areas underperform.
FAQ
The key risks of holding IBM include: (1) Financial risk from high debt levels, with a debt-to-equity ratio of 2.06, which could strain cash flow if interest rates rise. (2) Competitive risk from AI-native firms like Pegasystems and Amazon, which are capturing IT budgets, as evidenced by IBM's Q2 revenue miss. (3) Macro risk from a potential economic slowdown, which could reduce enterprise IT spending. (4) Company-specific risk of execution failure in its AI strategy, which could lead to further earnings misses and a potential dividend cut. The most severe risk is a prolonged revenue decline, which could push the stock down to the analyst low target of $174, a 25.9% downside from the current price.
The 12-month forecast for IBM is mixed, with a base case probability of 50% that the stock trades in the $220-$260 range, aligning with the analyst average target of $245.35. The bull case, with a 25% probability, sees the stock reaching $280-$350 if the company successfully executes its AI strategy. The bear case, also with a 25% probability, could see the stock fall to $174-$200 if revenue declines continue. The most likely scenario is the base case, assuming IBM stabilizes after the Q2 miss and returns to modest growth. However, the wide range of analyst targets underscores the high uncertainty, and the actual outcome will depend on IBM's ability to navigate the AI transition.
IBM appears undervalued relative to its growth prospects, as indicated by a PEG ratio of 0.35 and a forward P/E of 17.85x, which is lower than the trailing P/E of 26.07x. This suggests that the market expects significant earnings growth, but the recent miss has cast doubt on those expectations. Compared to the broader tech sector, IBM's valuation is not excessive, but it is not a deep value stock either. The market is pricing in a recovery, but the wide analyst target range of $174 to $350 reflects high uncertainty. If IBM meets consensus EPS estimates of $12.56, the stock is undervalued; if it misses again, it could be fairly valued or even overvalued.
IBM is a good buy for long-term investors seeking a stable dividend and value exposure, but it carries significant near-term risks. The stock trades at a forward P/E of 17.85x, which is below the market average, and offers a dividend yield of 2.27%, supported by strong free cash flow of $14.584 billion. However, the recent Q2 2026 earnings miss and profit warning have created uncertainty, and the stock has underperformed the S&P 500 by 23.6% over the past year. If you have a time horizon of 3-5 years and believe IBM can successfully pivot to AI, the current price may offer a good entry point. But for short-term traders, the stock's volatility and negative momentum make it a risky bet.
IBM is more suitable for long-term investment due to its low beta of 0.708, stable dividend yield of 2.27%, and strong free cash flow, which provide a cushion against volatility. The company's strategic investments in hybrid cloud and AI, such as the HRL acquisition, are likely to take several years to bear fruit, making a holding period of at least 3-5 years appropriate. Short-term trading is risky given the stock's recent 25% plunge and negative momentum, as seen in its 17.5% decline over the past three months. For income-focused investors, IBM offers a reliable dividend, but for growth investors, the near-term outlook is uncertain. Therefore, a long-term horizon is recommended to ride out the volatility and benefit from potential AI-driven growth.